Amberstone Biosciences Revenue and Competitors

Location

$12.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Amberstone Biosciences's estimated annual revenue is currently $1.7M per year.(i)
  • Amberstone Biosciences's estimated revenue per employee is $77,500
  • Amberstone Biosciences's total funding is $12.2M.

Employee Data

  • Amberstone Biosciences has 22 Employees.(i)
  • Amberstone Biosciences grew their employee count by -8% last year.

Amberstone Biosciences's People

NameTitleEmail/Phone
1
CEO & Co-founderReveal Email/Phone
2
Director Research & Scientific LiaisonReveal Email/Phone
3
Graduate Student ResearcherReveal Email/Phone
4
BioengineerReveal Email/Phone
5
Associate ScientistReveal Email/Phone
6
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M50%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M4-50%N/AN/A
#6
$0.7M80%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1731%N/AN/A
Add Company

What Is Amberstone Biosciences?

We discover transformative therapeutic antibodies through innovative technologies and creative partnerships to benefit patients with unmet medical needs.

keywords:N/A

$12.2M

Total Funding

22

Number of Employees

$1.7M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Amberstone Biosciences News

2022-04-20 - Scientists identify potential new 'soldier' for cancer ...

... is a scientific advisory board member of and holds equity or stock options in, Amberstone Biosciences Inc, and META Pharmaceuticals Inc.

2022-04-20 - Sloan Kettering Institute scientists identify potential new ...

... is a scientific advisory board member of and holds equity or stock options in, Amberstone Biosciences Inc, and META Pharmaceuticals Inc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M22-4%N/A
#2
$3.5M22-8%N/A
#3
$5.3M2310%N/A
#4
$5M23-8%N/A
#5
$5.1M23-4%N/A